{
  "documents": [
    "H Y P E R T E N S I O N Prognostic Value of Blood Hypertension Variability and Average Blood Hypertension Levels in Patients With Hypertension and Diabetes GIANFRANCO PARATI, MD, FESC 1, 2, 3 CAROLINA LOMBARDI, MD, PHD 3 relationship of elevated blood pressure levels and JUAN EUGENIO OCHOA, MD 2, 3 GRZEGORZ BILO, MD, PHD 3 type 2 Diabetes with risk of target-organ PAOLO SALVI, MD, PHD 3 damage and CV events without any evidenceofBPthresholdlevel(811). Inline with these findings, evidence has also been provided that in hypertensive paE levatedbloodpressure(blood pressure)isamaTheaimofthepresentarticleistoreview tients with coexisting type 2 Diabetes, jor risk factor for cardiovascular the available evidence on the prognostic tightercontrolofclinicBPisparticularly (CV)eventsandmortality(1)anda importance of blood pressure mean levels and of blood pressure important in order to improve CV proleading contributor to the global disease variability (BPV) estimates and to crititection (1223). Notwithstanding the burden (2). Overwhelming evidence is cally evaluate whether antihypertensive current recommendation that OBP meanowavailableshowingthatBPmeasured treatment strategies should be targeted surementremainsthecornerstoneofhyin the office shows a linear relationship at reducing not only average blood pressure levels pertension diagnosis and management, withanumberofCVandrenaloutcomes butalsothedegreeofBPVinordertoopthereisnowageneralconsensusthatiso- aswellaswithoverallmortalityandthat timizeCVprotectionindiabeticpatients. lated OBP readings alone are no longer lowering of office blood pressure (OBP) with treatsufficient. This is because of several ment is effective in reducing morbidity Prognostic value of OBP values well-acknowledgedlimitationsthatcharandmortality(3, 4). However, application Consistent evidence from observational acterize OBP measurements, including over the last 40 years of techniques for studies has indicated that the risk of CV theirinabilitytotrackthedynamicbehavout-of-office blood pressure monitoring including morbidityandmortalityhasastrongand ior of blood pressure, the inherent inaccuracy of the home blood pressure monitoring (HBPM) and 24-h continuous relationship with OBP levels technique, the operator dependence of ambulatory blood pressure monitoring (ABPM) has (3), without any evidence of a threshold the auscultatory technique (observer ledtofurtherimportantfindings. Inpardowntoatleast115/75mmHg(4). Furbias, digit preference), variable interferticular, 1)averageBPmeasuredineverythermore, large meta-analyses of major ence by the white coat effect, and the daylifeconditionsmaybeanevenbetter interventional trials in hypertensive subinabilityofthisapproachtocollectinfor- predictor of CV outcomes than isolated jectshaveshownthatloweringOBPlevels mationonBPduringsubjectsusualactivOBP readings and 2) the extent of flucconferssignificantCVprotectionregard- itiesandoveralongperiodoftime. tuations of blood pressure over time may provide less of the drug class used with a direct Are out-of-office mean blood pressure levels supeadditional, independent prognostic inrelationship between the degree of OBP rior to OBP in predicting CV outformation compared with both isolated loweringandthemagnitudeofriskreduccomes? Theintroductionofout-of-office office readings and average ambulatory tionformostoftheoutcomesconsidered blood pressure measurement techniques (i. e. , HBPM blood pressure(ABP)levels, respectively. Thesefind- (7). and 24-h ABPM) over the past four ingsareofupmostrelevanceinthecaseof Patients with Diabetes and elevadecades has significantly improved the diabetic patients who are characterized tion in clinic blood pressure levels are at higher CV management of hypertension, overcomby a significantly higher risk of CV riskcomparedwithnondiabeticindividingsomelimitationsofOBP. Noninvasive events compared with nondiabetic indiuals (810). Evidence on this has been ABPM techniques, based on automated viduals, with Diabetes itself currently provided from several studies, showoscillometric arm cuff blood pressure readings, are consideredaCVdiseaseequivalent(5, 6). ing a continuous direct and synergic nowadays widely available and provide blood pressure measurements throughout the 24 h, c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c not only during daytime, but also at From1CardiovascularMedicine, UniversityofMilano-Bicocca, Milan, Italy; the2DepartmentofHealthScinight, when blood pressure levels are known to bear ences, UniversityofMilano-Bicocca, Milan, Italy; andthe3DepartmentofCardiology, S. LucaHospital, the strongest prognostic value (2428). IstitutoDiRicoveroeCuraaCarattereScientifico, IstitutoAuxologicoItaliano, Milan, Italy. Although, compared with ABPM, selfCorrespondingauthor: GianfrancoParati, gianfranco. paratiunimib. it.",
    "Nevertheless, it differ(Fig. 1). national hypertension management appears that compared with OBP, ABP guidelines to recommend the use of reductions are more closely related to Short-term BPV: measurement, ABPM and HBPM in clinical practice regression of subclinical cardiac organ mechanisms, and prognostic as a complement to conventional OBP damage (36) and to reductions in the relevance measurements(1, 29, 33, 34). risk of fatal and nonfatal CV events and Assessmentofshort-termBPV. ThedySuperior prognostic value of ABP over ingeneralmortality(51)inparticularwhen namicbehaviorofBPvaluesoverthe24-h OBP. As mentioned above, a major adnighttimeBPlevelsareconsidered(52). period was first shown through use of vantage of ABPM overOBPis its ability Superior prognostic value of home blood pressure intra-arterial blood pressure monitoring in ambulant toprovidemoreaccuratemeasurements over OBP. In general, the prognostic subjects (6567). Although an accurate of blood pressure and to better track blood pressure changes value of HBPM has also been found to assessmentofshort-termBPVwithinthe induced by antihypertensive treatment besuperiortothatofOBPmeasurements 24hrequirescontinuousBPmonitoring, aswellastheactualcoverageofagiven in hypertensive patients with or without its evaluation is also possible (although treatmentoverthe24-hperiod. Itisthus Diabetes(25, 27, 36, 41, 5359). Whenavlessprecisely)throughuseofintermittent, notsurprisingthatbothcross-sectional eragedoverafewdays, homeBPmeasurenoninvasive 24-h ABPM. From these reand longitudinal studies have shown a ments have been shown to significantly cordings, itispossibletocalculatetheSD superiorprognosticvaluefor24-h, daypredict the development of major CV of average systolic (SBP), diastolic (DBP), time, andnighttimeaverageABPvalues events (myocardial infarction, stroke, and mean blood pressure values over the 24 h, with compared with OBP. In these studies, and CV death), all-cause mortality, prothedaytimeandthenighttimeperiodssep- compared with OBP measures ABP valgression of chronic Kidney disease (60), aratelyconsidered(68). Giventheopposite ues were more closely associated with and functional decline in the elderly, clinical significance of short-term BPV hypertensive subclinical organ damage with HBPM being a better predictor of within daytime or nighttime on one side, andwithitschangesafterantihypertenCVmortality (fatal CVevents) thanOBP and of slower changes between day and sive treatment (3539), and more imin most (25, 5355, 5962) although not nightontheotherside, severalnewmethportantly, it was also more effective in in all (63) studies. As a general remark, ods for the separate assessment of slower predicting the development of CV however, there is less evidence supportcircadianBPfluctuationsandoftheresid- events (24, 25, 4042) as well as CV ingtheprognosticvalueofHBPMthanfor ual faster blood pressure changes occurring during care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S313 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome daytimeornighttimehavebeenproposed. are often inextricably intertwined. blood pressure increased compared with that in hyperThesemethods, whichallowexclusionof variations in the very short term (i. e. , tensivesubjectswithoutdiabetes(79). Althe contribution of circadian blood pressure changes beat to beat) and in the short term (i. e. , though fasting Blood glucose levels have fromtheestimateofoverall24-hBPV, inwithin24h)mainlyreflecttheinfluences beenfoundtobeamajordeterminantfor clude assessment of 1) weighted SD of ofcentralneuralfactorseitherinresponse thisincreaseinBPV, otherfactorssuchas the 24-h mean value (i. e. , the average of to behavioral challenges or as a result of diabetic autonomic dysfunction (which daytime and nighttime blood pressure SD, each rhythmic influences originating in the may induce significant impairment in weighted for the duration of the day and central nervous system, as well as the baroreflexsensitivity)andincreasedartenight periods, respectively) (69), 2) soinfluences of reflex autonomic modularialstiffnessmightalsoplayanimportant called average real variability (average tion (i. e. , an increased central symparole (7981). Interestingly, some studies of absolute differences between consecuthetic drive and reduced sensitivity of in the diabetic population have shown tivereadings)(70), or3)residualspectral arterial and cardiopulmonary reflexes plasma norepinephrine levels to be dicomponents of BPV (obtained by removmaybothleadtoanincreasedBPV)(73 rectly correlated to nighttime systolic ing main slower cyclic components 76). Inthiscontext, alsochangesinelastic BPV, suggesting a potential role of symthroughFourieranalysis)(71).",
    "Inthiscontext, alsochangesinelastic BPV, suggesting a potential role of symthroughFourieranalysis)(71). Thesepaproperties of large arteries (i. e. , an inpathetic activation for the increase in rameters, which focus on short-term blood pressure creasedarterialstiffness)(77)andtheefnighttime BPV observed in the diabetic changes and are not affected by the dipfects of humoral (insulin, angiotensin II, population (82). Several studies using pingphenomenon, havebeenshowntobe bradykinin, endothelin-1, and nitric ox24-h ABPM have also indicated an inbetterpredictorsoforgandamageandCV ide)andrheological(i. e. , bloodviscosity) creased prevalence of alterations in dayrisk than the conventional 24-h SD factors(78)mayplayarole. Inaddition, blood pressure to-night blood pressure changes in diabetic patients. (69, 70, 72). fluctuations also occur in response to the In particular, an impaired nocturnal blood pressure Mechanisms of short-term BPV. The mechanicalforcesgeneratedbyventilation. fall(i. e. , nondipping)orevenincreasein results of several studies trying to disenIn diabetic patients with hypertennighttimeBP(i. e. , risingpattern)hasbeen tangle the precise contribution of husion, overallBPV(assessedthroughSDof showntobecommoninthispopulation, moral, neural, andenvironmentalfactors average 24-h, daytime, or nighttime blood pressure with aprevalence thatmay be ashighas to BPV have indicated that these factors values) has been found to be frequently 30and31%, respectively(83). Proposed Figure1dDifferenttypesofBPV, theirdeterminants, andprognosticrelevanceforCVandrenaloutcomes. AHT, antihypertensivetreatment; estimated glomerular filtration rate, estimatedglomerularfiltrationrate; end-stage renal disease, end-stagerenaldisease; MA, microalbuminuria; myocardial infarction, myocardialinfarction; SOD, subclinical organ damage. Assessed in laboratory conditions. Cardiac, vascular, and renal SOD. BPV on a beat-by-beat basis has not been routinely measuredinpopulationstudies. ReprintedwithpermissionfromParati, Ochoa, andBilo(64). S314 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates mechanisms for these abnormalities in blood pressure values but also on BPV, which may organdamage(93, 102)andincreasedrisk circadian blood pressure rhythms include alterations independently add to CV risk over and of CV events (103) and mortality inautonomicCVmodulation(whichare above the contribution of elevated mean (28, 104). The risk of CV events is even frequently associated with Diabetes) blood pressure levels. Recent reports of the InternahigherforpatientsinwhomBPincreases (84, 85) but also other conditions such tional Database on Ambulatory blood pressure in rather than decreases at night (104, 105) asobstructivesleepapnea, commonlyobrelation to Cardiovascular Outcome whilethepredictiverelevanceofextreme servedinobesediabeticsubjects(86). haveconfirmed that indices ofBPVsuch dippingremainscontroversial (104). RePrognostic significance of short-term as the weighted 24-h blood pressure SD and the markably, nondippingprofileofBPisfreBPV. The degree of BPV is in general average real variability (70) may predict quently accompanied by increased roughlyproportionaltomeanBPvalues, outcome, buttheyimprovepredictionof nocturnal meanBP levels(i. e. , nighttime and this dependence of BPV on average the composite CV events provided by blood pressure. 125/75 mmHg) (101). However, BPhasledtomethodsforassessingBPVin meanBPlevelsbyonlyasmallpercentage whether it is the reduction in nocturnal normalizedunitsaimedataccountingfor (100). Such analysis, however, is limited blood pressure dipping or the increase in absolute average blood pressure level. This can be done by by the lack of standardization of blood pressure relevel of average blood pressure at night that really computing blood pressure coefficient of variation, cordings performed in different counmatters is an issue still under investigawhile in the research setting this issue is tries. tion (28, 47). In addition, evidence is overcome by adjusting in multivariate In diabetic patients, the incidence of also available that an increased morning models the impact of BPV on clinical coronaryarterydiseasehasbeenshownto blood pressure surge is associated with a higher outcome for the concomitant influence be significantly greater in patients with incidence of CV events and mortality of mean blood pressure levels. Early studies using increased24-hsystolicBPV(67vs. 11%; (94, 95, 103, 106). However, the actual 24-hintra-arterialABPMforthefirsttime P, 0. 0005). Interestingly, nighttimesysprognostic value of morning blood pressure surge is showedthatBPV(quantifiedastheSDof tolicBPVwasanindependentriskfactor stillamatterofdebatedue, ononehand, the 24-h, day, and night mean values) for coronary artery disease (odds ratio to the difficulties in identifying the most increases from normotensive to hyper3. 1382; P, 0. 05)(82).",
    "1382; P, 0. 05)(82). reliablemethodfordefiningandassessing tensive subjects, the increase in blood pressure SD thisparameterandontheotherhand, to being proportional to the increase in Day-to-night blood pressure profiles: assessment the significant correlation between two mean blood pressure, with no change in the coeffiand prognostic relevance features of the 24-h blood pressure profile with concient of variation (65). Interestingly, an Assessment of day-to-night blood pressure profiles tradictoryprognosticsignificance: thedeincrease in BPV was also shown within with ABPM. In addition to providing gree of morning blood pressure surge (a potentially individuals, asmeanBPlevelsofdifferent information on mean blood pressure levels and on risky phenomenon) and the degree of subperiods within the 24 h increased relativelyfastBPchangesduringselected blood pressure fall at night (a potentially protective (65). subperiods over the 24 h, ABPM also phenomenon)dacorrelationthatmakes Evidence from longitudinal and obmakes possible the identification of theclinicalinterpretationofthedegreeof servational studies has indicated that slowerBPfluctuationsoccurringbetween morningBPsurgemoredifficult. Indeed, short-term BPV within the 24 h may day and night, which are significantly theadverseprognosticimpactofablunted have a nonmarginal contribution to CV influenced both by the subjects level of or inverted nighttime blood pressure fall (which is risk. Byusingeitherintra-arterialornonactivityduringdaytimeandbythesleep/ associated with a blunted morning blood pressure invasive blood pressure monitoring, several studies wakefulnesscycle. Byconsideringthedesurgeas well) seemsdifficult toreconcile haveindeedshownthatcardiac, vascular, gree of blood pressure change from awake to sleep, with the hypothesis that an excessive andrenalorgandamageforagiven24-h different patterns of circadian blood pressure variamorning blood pressure surge is also predictive of a blood pressure mean value is more prevalent and tionmaybeidentifiedinrelationtonocworse outcome. A recent large cohort severe as 24-hBPVincreases (66, 8792) turnal blood pressure fall and morning blood pressure surge. In study in hypertensive patients showed (Fig. 2). the general population, blood pressure falls on averthat a blunted day-night blood pressure dip but not Most importantly, prospective studageby1020%ofdaytimevaluesduring an increased morning blood pressure surge was the ieshaveprovidedevidencethataninitial sleep, a phenomenon referred to as dipkey predictor of CV outcomes, probably increase in BPV within the 24 h is an ping. DippersexhibitingnighttimeBPfall becauseofthesuperiorreproducibilityof independent predictor of progression of. 20%areknownasextremedippers. In nocturnal blood pressure compared with earlysubclinical organ damage (i. e. , increased some individuals, nocturnal decrease in morning blood pressure surge (107). When focusing left ventricular mass index or carotid blood pressure is blunted (non-dippers, with a fall on a diabetic population, several studies intima-media thickness) (92, 93), CV innighttimeSBPandDBP, 10%ofdayhave indicated that a nondipping profile events (71, 72, 9497), and CV mortality time blood pressure but still presenting some reducandinparticulararisingnightBPpattern (71, 72, 9399). In particular, data from tion compared with awake blood pressure) or even maybeofrelevanceforCVprediction. In the Pressioni Arteriose Monitorate e increases (so-called risers or inverted either type 1 (102, 108) or type 2 (109 LoroAssociazioni(PAMELA)studyfound dippers) compared with daytime values 112) diabetic subjects, several studies the risk of CV death not only to be in- (101). have indicated that elevated SBP during versely related to day-night DBP fall Prognostic relevance of alterations in nighttimesleepmayprecededevelopment (Fig. 3)butalsotobearasignificantposday-to-night blood pressure changes. Therelevance of renal damage (assessed trough microitiverelationshipwithresidualshort-term of alterations in circadian blood pressure profiles for albuminuria) and contribute to progresdiastolicBPV(71). CVprognosishasbeenexploredinseveral sion of renal damage when nephropathy Overall, this evidence supports the studies. Subjects in whom nocturnal blood pressure isalreadypresent. Evidencehasalsobeen concept that the adverse CV consequenreduction is blunted have been reported provided that a nondipping pattern of cesofhighBPdependnotonlyonmean tohaveagreaterprevalenceofsubclinical blood pressure is associated with an increased care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S315 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome Figure2dA: Short-termBPVandsubclinicalorgandamage(cross-sectionalstudy). Rateandseverityoftarget-organdamageinpatientswith essentialhypertensiondividedintoquintilesofincreasing24-hmeanintra-arterialBP(MAP). Patientsineachgroupwerefurtherclassifiedintotwo categoriesaccordingtowhetherthebetween-half-hourSDofmeanintra-arterialBPwasbeloworabovetheaveragevariabilityofthegroup. Within eachgroup, thetwoclasseshadsimilar24-hmeanintra-arterialBPvalues. Foreachclass, theseverityoftarget-organdamagewasexpressedasthe S316 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates and treatment regimen remain stable.",
    "diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates and treatment regimen remain stable. Thus, HBPM appears more appropriate forthelong-termassessmentofBPVand blood pressure control than repeated office or ABP measurements. Prognostic significance of day-by-day BPV. Recent studies exploring the prognostic role of BPV identified by HBPM have indicated that an increased day-byday variability in home blood pressure values is associated with a higher prevalence and severity of cardiac, vascular, and renal organ damage (120) and with an increased risk of fatal and nonfatal CV Figure3dKaplan-MeiercurvesforCVmortalityinsubjectswithday-nightDBPdifference(A) events(121, 122). Arecentcross-sectional andresidualvariability(B)above(blacklines)andbelow(graylines)themedianvalueofthe analysis in a population of never-treated population. ModifiedwithpermissionfromManciaetal. (71). hypertensive patients showed an increased day-by-day home systolic BPV mortalityrate, regardless ofdiabetestype inconstant accuracy of OBP readings to be associated with the severity of car- (113). Of note, the combination of non- (Fig. 1) (119). Thus, factors influencing diac (i. e. , left ventricular mass index), dippingandsubsequentrenalimpairment thedegreeofBPcontrol(i. e. , patientsadmacrovascular (i. e. , increased carotid inwasshowntobeassociatedwiththehigh- herenceto treatment and properdosing/ tima-media thickness), and microvascuest mortality rate (113). However, other titration of antihypertensive treatment) lar (i. e. , urinary albumin-to-Creatinine studies in type 2 diabetic subjects have orerrorsinBPmeasurementmayindue ratio) organ damage regardless of the foundmeannighttimeSBPtobeastronger courseinfluenceday-by-daybutespecially mean home blood pressure level, suggesting that predictor of organ damage and fatal and visit-to-visit BPV. In particular, patients homesystolicBPVmayaddtoprediction nonfatalvasculareventsthanthenondippoor compliance with antihypertensive ofhypertensivesubclinicalorgandamage pingpatterninnocturnalSBP(114). treatment may influence long-term BPV, over and above mean home SBP (120). as dose omission or delay in drug intake When it comes to prediction of major Long-term BPV duringthefollow-upperiodmayalsoconCV events, the Ohasama study provided blood pressure has been shown to exhibit important tribute to an increased day-by-day and the first evidence that an increased dayvariations notonlyin theshort term but visit-to-visitBPV. by-day systolic home BPV is associated alsoovermoreprolongedperiodsoftime Assessment of day-by-day BPV. In the with an increased risk of a composite of (i. e. , day-by-day, visit-to-visit, orseasonal timelineofBPV, day-by-dayBPVfindsits cardiac and stroke mortality, but only BPvariations). Althoughtheselong-term position somewhere between short-term withasignificantriskofstrokemortality, blood pressure variations have been shown to be a BPV (i. e. , within the 24 h) and visit-towhen the components of the main end reproducibleandnotarandomphenomvisit BPV (i. e. , within weeks, months, or point were independently considered enon(115), evidenceislimitedaboutthe years). Measuresofthisparticulartypeof (121). More recently, evidence on the factors responsible for blood pressure changes beBPV can be obtained by means of ABPM prognostic value of day-by-day home tween visits spaced by weeks, months, performed over consecutive days (i. e. , BPV was provided in a cohort of adults oryearsinobservationalstudiesandclinover 48 h) or, more easily, by means of fromthegeneralpopulationintheframe ical trials (116118). Long-term BPV homeBPmeasurementsperformedbypaof the Finn-Home Study (122) showing mightnotentirelyconsistofspontaneous tientsoversubsequentdaysinfairlystanincreasing levels of day-by-day home blood pressure variations or reflect the same physiodardized conditions. Although HBPM BPV to be associated with a higher risk logical CV control mechanisms of shortmay not provide the same extensive inofCVeventsevenafteradjustmentsfor term blood pressure fluctuations, but it may also be formation on 24-h blood pressure patterns as ABPM ageandmeanhomeBPlevel. TheprogtheresultofimperfectstabilityofBPcon- does, it may provide information on blood pressure nostic role of day-by-day BPV is also trolintreatedsubjects(inparticular, visitchanges over a longer but still relatively supported by the demonstration by to-visit blood pressure variations during follow-up), short time (several days), when both Matsui et al. (120) that the maximum or additionally, it might reflect the subjects physiological characteristics value of HBP over a given monitoring averagescoreaccountingforboththepresenceandextentoftarget-organdamage. Thescorerangedineachpatientfrom0(eithernoclinicalevents orelectrocardiogram, chestradiograph, fundus, orrenalfunctionalterations)to3(majoralterationsontheelectrocardiogram, chestradiograph, or fundusplusaclinicalevent, renalabnormality, orboth). Foranylevelof24-hmeanintra-arterialBP, patientsinwhom24-hBPVwaslowhad alowerprevalenceandseverityoftarget-organdamagethanthoseinwhom24-hBPVwashigh. B: Rateandseverityoftarget-organdamageandleft ventricularmassindex(LVMI)inthesamepatientsasinAafter7. 4yearsoffollow-up. Patientsweredividedintoquartilesofincreasing24-hmean intra-arterialBP. Patientsineachgroupwerefurtherclassifiedintotwocategoriesaccordingtowhetherthebetween-half-hourSDofmeanintraarterialBPwasbeloworabovetheaveragevariabilityofthegroup. Withineachgroup, thetwoclasseshadsimilar24-hmeanintra-arterialBP values. Foreachclass, theseverityoftarget-organdamagewasexpressedastheaveragescore, asassessedinAwiththeadditionofechocardiographicdata. BPV(between-half-hour SDof24-h meanintra-arterialBP)attheinitialevaluationwasasignificantpredictoroftarget-organ damageatfollow-up, indicatingthatthecardiovascularcomplicationsofhypertensionmightdependonthedegreeof24-hBPV. Modifiedwith permissionfromParatietal. (66)(A)andFrattolaetal. (92)(B). care. diabetesjournals.",
    "Patientsweredividedintoquartilesofincreasing24-hmean intra-arterialBP. Patientsineachgroupwerefurtherclassifiedintotwocategoriesaccordingtowhetherthebetween-half-hourSDofmeanintraarterialBPwasbeloworabovetheaveragevariabilityofthegroup. Withineachgroup, thetwoclasseshadsimilar24-hmeanintra-arterialBP values. Foreachclass, theseverityoftarget-organdamagewasexpressedastheaveragescore, asassessedinAwiththeadditionofechocardiographicdata. BPV(between-half-hour SDof24-h meanintra-arterialBP)attheinitialevaluationwasasignificantpredictoroftarget-organ damageatfollow-up, indicatingthatthecardiovascularcomplicationsofhypertensionmightdependonthedegreeof24-hBPV. Modifiedwith permissionfromParatietal. (66)(A)andFrattolaetal. (92)(B). care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S317 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome time is a significant predictor of events incidenceofcardiac(i. e. , diastolicdysfuncstroke, showedasteepreductionastheperin a population of elderly hypertensive tion)(127), macrovascular(i. e. , increased centageofon-treatmentvisitswithBPconpatients. intima-media thickness and stiffness) trolled(i. e. , blood pressure, 140/90mmHg)increased The prognostic role of day-by-day (128), microvascular (i. e. , development throughoutthetreatmentperiodindepenhome-measuredBPVinpredictingdevelof microand macroalbuminuria and redently of the achieved control of mean opment/progression of nephropathy in nal vascular atherosclerosis) (129, 130), clinicBP(118)(Fig. 4). type 2 diabetic patients has also been and cerebral (i. e. , white matter hyperinThe prognostic relevance of visit-toexploredinseveralstudies(123, 124). Ina tensity volume and presence of brain invisitBPVshowninthesestudiessupports large cohort of Japanese subjects with farctions) (131) organ damage as well as the recommendation of avoiding incontype2diabetes, increasingvaluesofdaywithendothelialdysfunction(132). sistentBPcontrolandlargeBPdifferences by-dayvariabilityinhomesystolicBP(asLongitudinal studies and post hoc from one visit to another, not only by a sessedthroughthecoefficientofvariation analyses of clinical trials in hypertension proper dosing/titration of antihypertenof blood pressure measures performed over 14 conhave found increasing values of intrasive treatment, but also by improving secutive days) were positively correlated individualvisit-to-visitvariabilityinconpatients adherence to treatment. Howwith urinary albumin excretion (UAE) ventionalofficeorABP(asassessedbythe ever, while in treated hypertensive and associated with an increased risk of SD or the coefficient of variation of the patients at High CV risk an increased macroalbuminuria(UAE300mgzg 21 averagein-treatmentBP)tobepredictive visit-to-visit BPV may be prognostically Creatinine). Remarkably, afteradjustment of cerebrovascular (116, 133135) and relevant(asshownintheINVESTstudy), for common confounders and mean blood pressure coronary fatal and nonfatal events (134 inmildlytomoderatelytreatedhypertenlevels, CVsofmorningSBP, morningDBP, 137) and of all-cause mortality (117) insivepatients, BPVbetweenvisitshasbeen and evening SBP remained independent dependentlyofmeanofficeorABPvalues. showntomakelittleornocontributionto predictors for UAE and were associated In some analyses, the predictive value of CV risk prediction over mean blood pressure levels withasignificantriskformacroalbuminuria intraindividualvisit-to-visitBPVhasbeen (125). of 1. 35 (P, 0. 05), 1. 29 (P, 0. 05), and showntobeevenhigherthanthatofavA post hoc analysis of the Diabetes 1. 44(P, 0. 05), respectively. erage blood pressure during treatment, suggesting ControlandComplicationsTrial(DCCT) Assessment of visit-to-visit BPV. In thattheprotectiveeffectofantihyperteninvestigatedwhethermeanBPvaluesand clinical practice, obtaining blood pressure measuresive treatment depends not only on the annual visit-to-visit BPV (as assessed ments over a consistent number of visits magnitude of the achieved mean blood pressure rethrough SD of SBP and DBP) might intoachieveameaningfulestimateofvisit- duction but also on the consistency of fluencethedevelopmentofmicrovascular to-visitBPVisusuallydifficult. Moreover, BPreduction(i. e. , thestabilityoftheoncomplications in initially normotensive OBP readings obtained in the clinic may treatmentBPcontroloverthelongterm). type 1 diabetic patients. Overall, mean not provide information on blood pressure during Thishasbeensupportedbyresultsofthe SBP and SD of SBP were related to an subjects usual activities and over a long International Verapamil-Trandolapril increased risk of development/progresperiod of time, being thus unable to (INVEST) Study conducted in a hysion of nephropathy with an odds ratio offer a representative evaluation of papertensive population at High CV risk foralbuminuriaof1. 005(95%CI1. 002 tients actual blood pressure burden. OBP is thus an (i. e. , allofwhomhadahistoryofcoronary 1. 008, P, 0. 001) and 1. 093 (1. 069 imperfectindicatorofBPcontrolandisfar disease). Inthisstudy, theincidenceoffatal 1. 117, P, 0. 001), respectively, foreach frombeinganidealmeanstoassessvisitandnonfatalCVevents, butinparticularof 1mmHgchange. Visit-to-visitvariability to-visit BPV. On the other hand, it has been shown that in treated hypertensive patientsthereproducibilityof24-hABPis clearly higher than that of isolated OBP readings(125). Thisisinpartduetothe fact that OBP can be altered by several environmentalstimuliandbythealertreactiongeneratedbythedoctorsornurses visit, whichhavenoeffecton24-hmean BPvalues. However, despite the relevant and extensive information on blood pressure levels within the 24 h provided by ABPM, it can neither be repeated frequently nor routinely applied to assess visit-to-visit BPV. Although measures performed by patients at home using HBPM may not provideinformationon24-hBPprofiles, theyseemtobeanappropriatealternative approachfortheassessmentoflong-term BPV(126).",
    "Although measures performed by patients at home using HBPM may not provideinformationon24-hBPprofiles, theyseemtobeanappropriatealternative approachfortheassessmentoflong-term BPV(126). Figure 4dHazard ratio (heart rate) of myocardial infarction (myocardial infarction) or stroke according to the perPrognostic relevance of visit-to-visit centageofvisitswithBP, 140/90mmHg. Thegroupinwhichthisoccurredin, 25%ofthevisits BPV. Recentstudieshaveshownincreaswastakenasreference. Datawereadjustedfordifferencesinbaselinedemographicdata, blood pressure, and ing values of visit-to-visit BPV to be CVriskfactorsaswellasforin-treatmentaverageBP. ReprintedwithpermissionfromMancia associated with a higher prevalence and etal. (118). S318 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025 ParatiandAssociates inSBPremainedasignificantpredictorof diabetic subjects have shown that treatachievedbytreatmentbutnottoon-treatalbuminuria even after adjustment for mentwithlong-actingcalciumantagonist ment visit-to-visit clinic or 24-h BPV meanBPlevels, independentlyaddingto (i. e. , lacidipine) is effective in reducing (146). Meta-analysesextendedtoalarger mean blood pressure in predicting the risk of nenotonlymeanABPvaluesduringthe24 number of trials using the post hoc apphropathy(129). h, daytime, andnighttimebutalsothereproach showed that differences between Evidence has also been provided in spectiveBPVsexpressedasSDandcoefficlasses ofantihypertensivedrugsintheir type2diabeticpatientsthatanincreasein cient of variation. Interestingly, reductions effectivenessinpreventingstrokedespite BPV may add to mean blood pressure values in in BPV in these studies were accompanied noorlittledifferenceinmeanBPmightbe predicting outcome as shown in a large byanimprovementofbaroreflexsensitivity, duetodifferentialclasseffectsoninterincohortoftype2diabeticpatientsinwhom suggesting a plausible mechanism for the dividual BPV (i. e. , between-patient disblood pressure levels were measured at every visit effectsofantihypertensivetreatmentinstapersion of mean blood pressure values during over a year. Increasing values of visit-tobilizingBPvariation(144). treatment)(147). However, amajorlimivisit systolic BPV (as assessed through More recently, a study in type 2 tation of interindividual BPV (or group coefficientofvariation)weredirectlycordiabetic patients explored whether treatBPV)is thatitrepresents the effect ofBP related with UAE and with arterial stiffment with an angiotensin II type 1 retreatmentinagroupofpatientsandcan- ness (assessed through pulse wave ceptorblockercouldimproveambulatory notaccuratelyreflectvariationsinBPvalvelocity) and inversely correlated with short-term BPV in hypertensive patients ues from visit to visit in individual ankle-brachial index (an indirect marker with diabetic nephropathy. After 12 subjects. Based on the prognostic releofatherosclerosis)(138). weeks of treatment, 24-h, daytime, and vanceofvisit-to-visitBPV, onecouldinfer nighttime short-term BPV (as assessed thatconsistencyofBPcontrolrepresents Potential implications of short-term through calculation of the coefficient of an additional important goal of antihyBPV for hypertension management variation) was significantly decreased by pertensive treatment (118). However, it Although it has been suggested that in treatment. Interestingly, thesereductions shouldbeconsideredthatmostevidence order to optimize CV protection in hyin BPV were accompanied by significant on visit-to-visit BPV in relation to propertensive patients, antihypertensive reductions in urinary Protein excretion, gression of organ damage or incidence treatmentshouldbetargetedatstabilizing brachial-ankle pulse wave velocity, and of CV events has been obtained from BPV in addition to reducing absolute blood pressure indicesofautonomicCVmodulation(i. e. , post hoc analyses of trial data and based values, most controlled trials using difLow frequencytoHigh frequency ratio, oncomparisonsbetweennonrandomized ferentantihypertensivedrugclassesasan anindexofsympathovagalbalance)suggroups, which may have introduced a active regimen have strongly supported gestingpotentialmechanismsforthebenlarge number of potential confounders, the preponderant role of mean blood pressure reeficial effects of angiotensin receptor thusunderminingthestudyconclusions. duction in achieving CV protection (7). blockadeondiabeticnephropathy(145). Atpresent, theonlyevidencethatmodConclusions ulation of 24-h BPV with antihypertenPotential implications of long-term Evidence from observational and intersivetreatmentmaybebeneficialinterms BPV for hypertension management ventional studies has indicated that the of CV protection comes from studies When it comes to reducing BPV in the riskofCVmorbidityandmortalityhasa making use of the smoothness index long term, recent post hoc analyses perstrong and continuous relationship with (i. e. , the ratio between the average of formed on the basis of the data of the meanBPlevels(3, 4)andthatloweringBP the24-hBPchangesinducedbyagiven Anglo-Scandinavian Cardiac Outcome levels confers significant CV protection medication and its SD) in assessing the Trial(ASCOT)andtheMedicalResearch regardless of the drug class used distribution of blood pressure reduction by treatCouncil Trial of Treatment of Hyperten- (7, 148). Out-of-officeBPlevelsmeasured ment (67, 139).",
    "Out-of-officeBPlevelsmeasured ment (67, 139). This index has been sioninOlderAdults(MRC-elderly)have either with ABPM or with HBPM have showntoberelatedtodrug-inducedrereportedthatintraindividualvisit-to-visit been shown to be even better predictors gression of target-organ damage at carBPV(i. e. , variabilityofanindividualsBP ofoutcomescomparedwithOBPandmay diac level (i. e. , left ventricular mass from visit to visit) may be differentially also allow identification of masked index) (67) as well as to drug-induced affected by antihypertensive drug classes hypertension, a condition that needs to reductionintheprogressionofchanges and that these differences might explain beproperlytreated, asitbearsanadverse incarotidarterywallthickness, partially the variable effects of blood pressure-lowering drugs CVprognosissimilartothatofsustained independent of basal mean blood pressure values in preventing outcome, with calcium hypertension. ABPM in diabetic subjects (139). channelblockerscoringbest(134). Howmaybeapowerfultoolforabetterstrat- Evidenceisavailablethatsomeclasses ever, contrasting results were observed ificationoftheCVriskrelatedtoelevated oforalantidiabetesdrugs(i. e. , thiazolidiin a post hoc analysis of the European blood pressure, whichinturnisasubstantialcontribnediones), maynotonlyhaveabeneficial Lacidipine Study on Atherosclerosis utortoCVmorbidityandmortalityindieffecton24-hBPlevelsbutalsoimprove (ELSA), in mild-to-moderate hypertenabetes. Moreover, ABPM may also be day-night blood pressure profile in diabetic subjects sivepatients, wherenosubstantialdifferhelpful in detecting alterations in auto- (140, 141). Althoughseveralstudiesindiencesbetweenab-blockerandacalcium nomiccontroloftheCVsystem, reflected abeticpatientshaveshowntheefficacyof antagonist in relation to intraindividual bytheabsenceofnocturnalBPfallorbya differentantihypertensivedrugclassesin visit-to-visitBPVwereobserved(125). Inreduced24-hheartratevariabilityandan controlling blood pressure levels over the 24 h deed, whenthepooleddataofthisstudy increased 24-h BPV. Despite the large (142, 143), nosignificantimpactondaywere analyzed, carotid intima-media bodyofevidencesupportingthepreponnightBPprofileshasbeenevidentinthese thicknessandCVoutcomeswererelated derantroleofaverageBPvaluesindeterstudies. However, somestudiesintype2 to the mean clinic or ambulatory SBP mining the CV risk associated with High care. diabetesjournals. org DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 S319 Downloaded from by guest on 31 December 2025 BPvariability, meanBP, andoutcome BPlevels, theextentoffluctuationsofBP ArterialHypertension: TheTaskForcefor 12. CollinsR, MacMahonS. Bloodpressure, over time may provide additional, indetheManagementofArterialHypertension antihypertensivedrugtreatmentandthe pendent prognostic information. EvioftheEuropeanSocietyofHypertension risks of stroke and of coronary Heart dence supporting this concept has been (ESH) and of the European Society of disease. BrMedBull1994; 50: 272298 Cardiology (ESC). J Hypertens 2007; 25: 13. Holman respiratory rate, Paul SK, Bethel MA, Neil providedbyseveralstudiesshowingthat 11051187 HA, MatthewsDR. Long-termfollow-up notonlyelevationinaverageBPlevelsbut 2. EzzatiM, LopezAD, RodgersA, Vander after tight control of Blood Hypertension in alsoanincreasedBPV(eitherintheshort Hoorn S, MurrayCJ; ComparativeRisk type2diabetes. NEnglJMed2008; 359: term or in the long term) may indepenAssessment Collaborating Group. Se15651576 dentlyaddtoCVriskpredictionoverand lectedmajorriskfactorsandglobaland 14. Holman respiratory rate, Paul SK, Bethel MA, above the contribution of elevated mean regionalburdenofdisease. Lancet2002; MatthewsDR, NeilHA. 10-yearfollowBPlevels. Althoughithasbeensuggested 360: 13471360 upofintensiveglucosecontrolintype2 that in order to achieve the highest CV 3. MacMahon S, Peto R, Cutler J, et al. Diabetes. NEnglJMed2008; 359: 1577 protection in hypertensive patients antiBlood Hypertension, stroke, and coronary 1589 hypertensive treatment should betargetHeart disease. Part 1, Prolonged differ15. Gaede P, Lund-Andersen H, Parving ences in Blood Hypertension: prospective HH, PedersenO. Effectofamultifactoedatnormalizing24-hBPVinadditionto observational studies corrected for the rial intervention on mortality in type 2 reducing absolute 24-h blood pressure levels, eviregression dilution bias. Lancet 1990; Diabetes. N Engl J Med 2008; 358: 580 denceisstilllimitedregardingthetargets 335: 765774 591 of BPV to achieve with antihypertensive 4. LewingtonS, ClarkeR, QizilbashN, Peto 16. UKProspectiveDiabetesStudy(UKPDS) treatment. Because 24-h ABPM has not R, Collins R; Prospective Studies ColGroup. Intensive Blood-glucose control been routinely used in large-scale trials laboration. Age-specific relevance of with sulphonylureas or insulin comon antihypertensive treatment, the prousual Blood Hypertension to vascular morpared with conventional treatment and tective effect of treatment-induced tality: ameta-analysisofindividualdata risk of complications in patients with changes in 24-h BPV with respect to the foronemillionadultsin61prospective type 2 Diabetes (UKPDS 33). Lancet concomitant changes in mean blood pressure levels studies. Lancet2002; 360: 19031913 1998; 352: 837853 5. Haffner SM, Lehto S, Rönnemaa T, 17. HanssonL, ZanchettiA, CarruthersSG, still needs to be properly documented. Pyörälä potassium, Laakso M. Mortality from et al. ; HOT Study Group.",
    "; Blood andriskofstroke. LancetNeurol2010; 9: (the RECORD study). Cardiovasc DiaHypertension Lowering Treatment Trialists 469480 betol2008; 7: 10 Collaboration. Effectsofdifferentblood 135. Eguchi potassium, Hoshide S, Schwartz JE, 142. RossingK, ChristensenPK, AndersenS, Hypertension-lowering regimens on major Shimada potassium, Kario potassium. Visit-to-visit and Hovind P, Hansen HP, Parving HH; Ircardiovasculareventsinindividualswith ambulatorybloodpressurevariabilityas besartaninPatientswithType2Diabetes and without Diabetes mellitus: results predictors of incident cardiovascular and Microalbuminuria Study. Comparof prospectively designed overviews of eventsinpatientswithhypertension. Am ativeeffectsofIrbesartanonambulatory randomized trials. Arch Intern Med JHypertens2012; 25: 962968 andofficebloodpressure: asubstudyof 2005; 165: 14101419 S324 DIABETESCARE, VOLUME36, SUPPLEMENT2, AUGUST2013 care. diabetesjournals. org Downloaded from by guest on 31 December 2025"
  ],
  "metadatas": [
    {
      "source": "s312.pdf",
      "chunk_id": 0,
      "content_type": "monitoring",
      "content_type_confidence": 4,
      "word_count": 589,
      "entity_count": 2,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "antihypertensive,monitoring",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "s312.pdf",
      "chunk_id": 2,
      "content_type": "monitoring",
      "content_type_confidence": 5,
      "word_count": 565,
      "entity_count": 3,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,antihypertensive,monitoring",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "s312.pdf",
      "chunk_id": 3,
      "content_type": "evidence",
      "content_type_confidence": 4,
      "word_count": 588,
      "entity_count": 3,
      "has_ckd": false,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "glomerular filtration rate,end-stage renal disease,insulin",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "s312.pdf",
      "chunk_id": 4,
      "content_type": "evidence",
      "content_type_confidence": 3,
      "word_count": 597,
      "entity_count": 3,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "nephropathy,albuminuria,monitoring",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "s312.pdf",
      "chunk_id": 5,
      "content_type": "evidence",
      "content_type_confidence": 4,
      "word_count": 590,
      "entity_count": 4,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "creatinine,antihypertensive,blood pressure control,monitoring",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "s312.pdf",
      "chunk_id": 6,
      "content_type": "evidence",
      "content_type_confidence": 4,
      "word_count": 596,
      "entity_count": 3,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "nephropathy,creatinine,adherence",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "s312.pdf",
      "chunk_id": 7,
      "content_type": "evidence",
      "content_type_confidence": 6,
      "word_count": 574,
      "entity_count": 2,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "nephropathy,antihypertensive",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "s312.pdf",
      "chunk_id": 8,
      "content_type": "evidence",
      "content_type_confidence": 6,
      "word_count": 570,
      "entity_count": 4,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "potassium,calcium,insulin,antihypertensive",
      "year": "2025",
      "organization": "Unknown"
    },
    {
      "source": "s312.pdf",
      "chunk_id": 15,
      "content_type": "evidence",
      "content_type_confidence": 4,
      "word_count": 98,
      "entity_count": 1,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "potassium",
      "year": "2025",
      "organization": "Unknown"
    }
  ],
  "ids": [
    "s312_0",
    "s312_2",
    "s312_3",
    "s312_4",
    "s312_5",
    "s312_6",
    "s312_7",
    "s312_8",
    "s312_15"
  ]
}